The study of the pathogenesis of preeclampsia has been hampered by a relative dearth of animal models. We developed a rat model of preeclampsia in which the excretion of a circulating inhibitor of Na/K ATPase, marinobufagenin (MBG), is elevated. These animals develop hypertension, proteinuria, and intrauterine growth restriction. The administration of a congener of MBG, resibufogenin (RBG), reduces blood pressure to normal in these animals, as is the case when given to pregnant animals rendered hypertensive by the administration of MBG. Studies of Na/K ATPase inhibition by MBG and RBG reveal that these agents are equally effective as inhibitors of the enzyme.
PridjianG, PuschettJB. Preeclampsia, part I: clinical and pathophysiological considerations. Obstet Gynecol Surv57: 598–618, 2002.
2.
PridjianG, PuschettJB. Preeclampsia, part II: experimental and genetic considerations. Obstet Gynecol Surv57: 619–640, 2002.
3.
ZhangJ, MeikleS, TrumbleA. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy22: 203–212, 2003.
4.
American College of Obstetricians and Gynecologists.Hypertension in Pregnancy. ACOG Technical Bulletin. 219:1–8, 1996.
5.
LindheimerMD. Hypertension in pregnancy. Hypertension22: 127–137, 1993.
6.
ConradKP. Animal models of pre-eclampsia: do they exist?Fetal Medicine Review2: 67–88, 1990.
MaynardSE, MinJY, MerchanJ, LimKH, LiJ, MondaiS, LibermannTA, MorganJP, SellkeFW, StillmanIE, EpsteinFH, SukhatmeVP, KarumanchiSA. Excess placental soluble fms-Iike tyrosine kinase 1 (sFltl) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest111: 649–658, 2003.
9.
Ianosi-IrimieM, VuH, WhitbredJ, PridjianC, NadigJD, WilliamsMY, WrennDC, PridjianG, PuschettJB. A rat model of preeclampsia. Clin Exp Hypertens8: 605–617, 2005.
10.
GravesSW, ValdesRJr, BrownBA, KnightAB, CraigHR. Endogenous digoxin-immunoreactive substance in human pregnancies. J Clin Endocrinol Metab58: 748–751, 1984.
11.
GravesSW, WilliamsGH. An endogenous ouabain-like factor associated with hypertensive pregnant women. J Clin Endocrinol Metab59: 1070–1074, 1984.
12.
DahlLK, KnudsenKD, IwaiJ. Humoral transmission of hypertension: evidence from parabiosis. Circ Res24(Suppl):21–33, 1969.
13.
de WardenerHE. The primary role of the kidney and salt intake in the aetiology of essential hypertension: part I. Clin Sci. 79: 193–200, 1990.
14.
de WardenerHE. The primary role of the kidney and salt intake in the aetiology of essential hypertension: part II. Clin Sci79: 289–297, 1990.
15.
BlausteinMP, HamlynJM. Sodium transport inhibition, cell calcium, and hypertension. The natriuretic hormone/Na+-Ca2+ exchange/hypertension hypothesis. Am J Med77(4A):45–59, 1984.
16.
HamlynJM, RingelR, SchaefferJ, LevinsonPD, HamiltonBP, KowarskiAA, BlausteinMP. A circulating inhibitor of (Na+ + K+) ATPase associated with essential hypertension. Nature300: 650–652, 1982.
17.
HamlynJM, BlausteinMP, BovaS, DuCharmeDW, HarrisDW, MandelF, MathewsWR, LudensJH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A88: 6259–6263, 1991.
18.
BlausteinMP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol232(5):C165–C173, 1977.
19.
de WardnerHE, ClarksonEM. Concept of natriuretic hormone. Physiol Rev. 65(3):658–759, 1985.
20.
SchonerW. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem269: 2440–2448, 2002.
21.
VuH, Ianosi-IrimieMR, PridjianC, WhitbredJM, DurstJM, BagrovAY, FedorovaOV, PridjianG, PuschettJB. The involvement of marinobufagenin in a rat model of human preelampsia. Am J Nephrol25: 520–528, 2005.
22.
DurstJ, VuH, Ianosi-IrimiM, PridjianC, BagovA, FedorovaO, PridjianG, PuschettJB. Antibodies to marinobufagenin reduce blood pressure in a rat model of preeclampsia. J Invest Med52: S318, 2004.
23.
BagrovAY, FedorovaOV. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+,K+-pump in human mesenteric arteries. J Hypertens16: 1953–1958, 1998.
24.
FedorovaOV, KolodkinNI, AgalakovaNI, LakattaEG, BagrovAY. Marinobufagenin, an endogenous α-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension37: 462–466, 2001.
25.
PettitGR, KamanoY, BruschweilerF, BrownP. Bufadienolides. 14. Synthesis of bufotalien, 15α-hydroxybufalin, and resibufogrnin. J Org Chem36: 3736–3739, 1971.
XieJT. Effects of resibufogenin from toad venom on isolated Purkinje fibers. Am J Chin Med, 2: 187–196, 2000.
28.
IwatsukiK, YusaT, KataokaY, SatoK. Experimental and clinical studies of resibufogenin. Tohoku J Exp Med86: 93–101, 1965.
29.
LaemmliUK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature227: 680–685, 1970.
30.
JorgensenPL. Purification and characaterization of (Na+ plus K+) ATPase. IV. Estimation of the purity of the molecular weight and polypeptide content per enzyme unit in preparations from the outer medulla of rat kidney. Biochem Biophys Acta356: 36–52, 1974.
31.
LancettaP, ReinachAL, CandiaO. An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem100: 95–97, 1997.
32.
NessRB, RobertsJM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol175: 1365–1370, 1996.
33.
von DadelszenV, MageeLA, RobertsJM. Subclassification of preeclampsia. Hypertens Pregnancy22: 143–148, 2003.
34.
XiongX, DemianczukNN, BuekensP, SaundersLD. Association of preeclampsia with high birth weight for gestational age. Am J Obstet Gynecol183: 148–155, 2000.
35.
GrangerJP, AlexanderBT, BennettWA, KhalilRA. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens14: 178S–185S, 2001.
36.
LuckingK, NielsenJ M, PedersenPA, JorgensenPL. Na-K-ATPase isoform (alpha 3, alpha 2, alpha 1) abundance in rat kidney estimated by competitive RT-PCR and ouabain binding. Am J Physiol271: F253–260, 1996.
37.
OutlandJ, AlperB, EzeC, PridjianG, PuschettJB. Human correlates of a rat model of preeclampsia. Am J Hypertens18: 185A, 2005.
